NCT06506565PHASE4Recruiting

Low-Dose Ketamine Infusion During Burn Wound Care

University of Tennessee

Start Date

7/8/2024

Completion Date

12/1/2025

Summary

The current standard of care (SOC) (i.e. fentanyl and midazolam) offers limited efficacy for preventing or relieving pain. Ketamine infusions may provide the benefits of analgesia, minimize adverse events, and reduce opioid use. The purpose of this study is to determine if adding a low dose ketamine infusion during wound care will safely provide pain relief for patients with burn injury.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Admitted to burn service with thermal injury Exclusion Criteria: * unable/unwilling to consent within 72 hours * unable to report NRS * known contraindication to ketamine * \< than 18 years of age * pregnant * incarcerated * TBSA over 50 %

Interventions

DRUG

Ketamine

DRUG

0.9% NaCl

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

BurnPainDissociationOpioid

Locations

Regional One Health

Memphis, Tennessee 38103

United States

Run studies, or work at a research site?

Corterve helps sites and sponsors reach patients who are looking for trials. It does not determine eligibility and does not promise an enrolment outcome.

For sponsors, CROs and sites

What Corterve sells to organisations, and the anti-kickback constraints it works within.

Services and published prices

Lay summaries for EU CTR Annex V, pre-screen filtration, recruitment-creative regulatory operations, feasibility reporting.

For research sites

One published licence rate, the same for every site, and the fees a site is never charged.